Gps Wealth Strategies Group, LLC Acurx Pharmaceuticals, Inc. Transaction History
Gps Wealth Strategies Group, LLC
- $705 Million
- Q1 2025
A detailed history of Gps Wealth Strategies Group, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 500 shares of ACXP stock, worth $360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$360
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
3.49MCall Options Held
100Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ2.04MShares$1.47 Million6.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA529KShares$381,1310.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$263,9340.08% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$123,4700.0% of portfolio
-
Morgan Stanley New York, NY106KShares$76,4640.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $8.32M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...